GLP-1 Drugs May Treat Addiction: Study Finds Reduced Risk

GLP-1 Drugs May Treat Addiction: Study Finds Reduced Risk

New research indicates that GLP-1 drugs, traditionally used for weight loss and diabetes, may also help reduce addiction risk. A study of over 600,000 veterans revealed that those using GLP-1 drugs for diabetes were 15-20% less likely to misuse substances like alcohol, opioids, and others. The study, published in The BMJ, also showed a decrease in overdose rates, hospitalizations, and mortality linked to substance use. Experts suggest these drugs could be a novel treatment option for addiction, though more rigorous studies are needed. Dr. Ziyad Al-Aly, a study author, noted that GLP-1 drugs influence a common biological mechanism involved in addiction, which may explain their broad impact. However, questions remain about long-term use and effectiveness across different substances and populations.